Pharmaceutical - Respiratory and Pulmonary, Dermatologicals


Popular Filters

Genentech Ph III study of omalizumab shows promise in CIU


Genentech, the US biotech subsidiary of Swiss drug major Roche (ROG: SIX), announced results from a Phase…

BiotechnologyDermatologicalsGenentechNovartisOmalizumabPharmaceuticalRegulationResearchRespiratory and PulmonaryRocheXolair

New Zealand's PHARMAC to fund alternative treatments for asthma, scabies from Merck


New Zealand's Pharmaceutical Management Agency PHARMAC is to fund a treatment for pre-schoolers with…

Asia-PacificDermatologicalsHealthcareMerck & CoPharmaceuticalPricingRespiratory and PulmonarySingulairStromectil

Back to top